Bispecific Playgrounds? No, Factory Floors
Developers Prepare for Future Biologics Work by Exploring a Multitude of Antibody Formats
This is Your Brain on DREADDs
Chemogenetics Provides a Noninvasive Tool for Precise Control of Neural Circuits
Bioprocessing Companies Push Limits of Upstream Technologies
Goal Is to Maximize Efficiency in Bioprocess Operations
Scaling Up Cell Therapy Manufacturing
Moving Forward with an Early-on Strategy
Kenneth Thompson Ph.D.
Kenneth Thompson, Ph.D., is R&D scientist for Thermo Fisher Scientific.
More GEN Content From This Contributor
- Tutorials: High-Titer Recombinant Protein Production